webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-Ala-Ala-Asn(Trt)-OH

  CAS No.: 1951424-92-2   Cat No.: BADC-01025   Purity: >98.0% 4.5  

Fmoc-Ala-Ala-Asn(Trt)-OH is a protected peptide linker precursor used in ADC synthesis for site-specific drug release and enhanced conjugate stability.

Fmoc-Ala-Ala-Asn(Trt)-OH

Structure of 1951424-92-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C44H42N4O7
Molecular Weight
738.83
Shipping
Room temperature
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
FMc-Ala-Ala-Asn(Trt)-OH
IUPAC Name
(2S)-2-[[(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoyl]amino]propanoyl]amino]-4-oxo-4-(tritylamino)butanoic acid
Canonical SMILES
CC(C(=O)NC(CC(=O)NC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O)NC(=O)C(C)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46
InChI
InChI=1S/C44H42N4O7/c1-28(45-40(50)29(2)46-43(54)55-27-37-35-24-14-12-22-33(35)34-23-13-15-25-36(34)37)41(51)47-38(42(52)53)26-39(49)48-44(30-16-6-3-7-17-30,31-18-8-4-9-19-31)32-20-10-5-11-21-32/h3-25,28-29,37-38H,26-27H2,1-2H3,(H,45,50)(H,46,54)(H,47,51)(H,48,49)(H,52,53)/t28-,29-,38-/m0/s1
InChIKey
PMEYZYXHXRXGHF-HXUMPODJSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
-20°C
Form
Solid

Fmoc-Ala-Ala-Asn(Trt)-OH, a protected tripeptide crucial in peptide and protein synthesis, offers a multitude of applications:

Peptide Synthesis: In the realm of solid-phase peptide synthesis (SPPS), Fmoc-Ala-Ala-Asn(Trt)-OH plays a pivotal role in crafting custom peptides. Its Fmoc group shields the amino terminus throughout synthesis, ensuring precise elongation of the peptide chain. This reagent is invaluable for generating intricate peptides tailored for both research and therapeutic purposes.

Protein Engineering: Through the integration of Fmoc-Ala-Ala-Asn(Trt)-OH into protein sequences, scientists can engineer novel proteins with modified properties and functions. The Trt protecting group on the Asn residue enables selective deprotection, facilitating precise alterations to the target protein. This capability is essential for exploring structure-function relationships of proteins and designing innovative biologics.

Bioconjugation: Fmoc-Ala-Ala-Asn(Trt)-OH finds application in crafting peptide conjugates, where peptides are linked to various molecules like drugs or nanoparticles to enhance their efficacy. Particularly in targeted drug delivery systems, the peptide serves as a guiding beacon, directing therapeutic agents to specific cells or tissues. Customization of the peptide sequence elevates the specificity and performance of these conjugates.

Immunology Research: Within immunology, synthetic peptides containing Fmoc-Ala-Ala-Asn(Trt)-OH are harnessed to develop antigenic sequences for vaccine formulations and antibody production. These peptides mimic pathogen epitopes, enabling the investigation of immune responses. Such applications are pivotal in the development of novel vaccines and deepening our understanding of immune mechanisms at the molecular level.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Fmoc-GGFG-Glycolic acid | Fmoc-GGFG-OH | DC4 | DACN(Tos2) | Anetumab ravtansine | m-PEG6-SS-PEG6-methyl | SG3199 | Azido-PEG8-propionic acid | Azido-PEG5-propionic acid | Azido-PEG4-propionic acid | Fmoc-Ala-Ala-Asn(Trt)-OH
Send Inquiry
Verification code
Inquiry Basket